64 Patents
- US123516162025Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122972452025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122972542025Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122811462025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122757682025In Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122757752025Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122757762025Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122583822025Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122470572025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122408772025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122408782025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - 0 cites
- US122264672025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - 0 cites
- US122214682025Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122216262025Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121939972025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121939982025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121939992025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121955062025Immunotherapy with A*01 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US121955072025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121955082025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121955092025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121862762025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121862772025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121718192024Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121680432024Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121629172024B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US121039842024Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120845222024Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120763792024A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US120654712024B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US120594582024Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US120603992024Immunotherapy with A*01 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - 0 cites
- US120051052024Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US119997742024Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US119458502024B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US119381762024Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US119393662024Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US119394002024Immunotherapy Against Several Tumors Including Lung Cancer
Immatics Biotechnologies GmbH
0 cites - US119394012024Immunotherapy Against Several Tumors Including Lung Cancer
Immatics Biotechnologies GmbH
0 cites - US119326782024Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US118903332024Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118903342024Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118722702024A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118665172024Immunotherapy Against Several Tumors Including Lung Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118590172024Immunotherapy Against Several Tumors Including Lung Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118331932023A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118331942023Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118264102023Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118144462023Immunotherapy Against Several Tumors Including Lung Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117595072023Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - 0 cites
- US116800892023B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116739172023Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116676852023B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116291772023B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116187742023Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116074462023Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116083702023Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115769552023A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115541642023A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites